Monsanto Co. (NYSE:MON) has been given a $128.00 target price by analysts at JPMorgan Chase & Co. in a report released on Thursday. The brokerage presently has a a “buy” rating on the stock. JPMorgan Chase & Co.’s price objective would indicate a potential upside of 23.67% from the company’s current price.
A number of other equities analysts have also commented on MON. Zacks Investment Research upgraded shares of Monsanto from a “sell” rating to a “hold” rating in a research report on Wednesday, June 8th. Piper Jaffray Cos. restated an “overweight” rating and issued a $127.00 price target (up from $95.00) on shares of Monsanto in a research report on Monday, June 13th. Argus restated a “buy” rating and issued a $128.00 price target (up from $111.00) on shares of Monsanto in a research report on Wednesday, June 15th. Goldman Sachs Group Inc. set a $92.00 target price on shares of Monsanto and gave the stock a “sell” rating in a research report on Monday, June 27th. Finally, Vetr upgraded shares of Monsanto from a “buy” rating to a “strong-buy” rating and set a $116.55 target price on the stock in a research report on Monday, June 27th. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $114.67.
Monsanto (NYSE:MON) traded up 0.09% on Thursday, reaching $103.59. 1,577,526 shares of the company’s stock traded hands. Monsanto has a 52-week low of $83.73 and a 52-week high of $114.26. The firm’s 50 day moving average price is $104.88 and its 200 day moving average price is $101.34. The firm has a market capitalization of $45.33 billion, a PE ratio of 45.59 and a beta of 1.19.
Monsanto (NYSE:MON) last released its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 EPS for the quarter, beating the Zacks’ consensus estimate of ($0.02) by $0.09. The firm had revenue of $2.56 billion for the quarter, compared to analyst estimates of $2.38 billion. Monsanto had a net margin of 9.89% and a return on equity of 46.07%. The company’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.19) earnings per share. On average, analysts predict that Monsanto will post $4.89 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, October 7th will be issued a $0.54 dividend. This represents a $2.16 annualized dividend and a yield of 2.09%. The ex-dividend date is Wednesday, October 5th. Monsanto’s dividend payout ratio is currently 71.05%.
In other Monsanto news, COO Brett D. Begemann sold 27,980 shares of the firm’s stock in a transaction dated Thursday, July 14th. The shares were sold at an average price of $103.62, for a total value of $2,899,287.60. Following the transaction, the chief operating officer now directly owns 102,480 shares of the company’s stock, valued at approximately $10,618,977.60. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Michael K. Stern sold 12,797 shares of the firm’s stock in a transaction dated Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the completion of the transaction, the chief executive officer now directly owns 21,583 shares in the company, valued at $2,196,501.91. The disclosure for this sale can be found here. 0.88% of the stock is currently owned by company insiders.
Institutional investors have recently added to or reduced their stakes in the stock. Virginia Retirement System acquired a new stake in Monsanto during the first quarter valued at approximately $626,000. JPMorgan Chase & Co. increased its position in shares of Monsanto by 2.3% in the first quarter. JPMorgan Chase & Co. now owns 828,673 shares of the company’s stock worth $72,708,000 after buying an additional 18,961 shares during the period. NN Investment Partners Holdings N.V. purchased a new position in shares of Monsanto during the first quarter worth about $13,877,000. Advisor Partners LLC increased its position in shares of Monsanto by 34.6% in the first quarter. Advisor Partners LLC now owns 6,215 shares of the company’s stock worth $545,000 after buying an additional 1,598 shares during the period. Finally, M&T Bank Corp increased its position in shares of Monsanto by 16.4% in the first quarter. M&T Bank Corp now owns 77,720 shares of the company’s stock worth $6,820,000 after buying an additional 10,927 shares during the period. 79.02% of the stock is currently owned by hedge funds and other institutional investors.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.